Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.9538
+0.0272 (2.94%)
Feb 26, 2026, 3:08 PM EST - Market open
Beyond Air Employees
Beyond Air had 61 employees as of March 31, 2025. The number of employees decreased by 46 or -42.99% compared to the previous year.
Employees
61
Change (1Y)
-46
Growth (1Y)
-42.99%
Revenue / Employee
$113,508
Profits / Employee
-$508,213
Market Cap
10.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 61 | -46 | -42.99% | 61 | 0 |
| Mar 31, 2024 | 107 | 9 | 9.18% | 107 | 0 |
| Mar 31, 2023 | 98 | 36 | 58.06% | 98 | 0 |
| Mar 31, 2022 | 62 | 21 | 51.22% | 62 | 0 |
| Mar 31, 2021 | 41 | 18 | 78.26% | 41 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Vicarious Surgical | 121 |
| Lifeward | 80 |
| PAVmed | 39 |
| enVVeno Medical | 37 |
| Movano | 32 |
| Tenon Medical | 27 |
| Sintx Technologies | 20 |
XAIR News
- 6 days ago - Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections - GlobeNewsWire
- 13 days ago - Beyond Air, Inc. (XAIR) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 6 weeks ago - XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire
- 3 months ago - Beyond Air® Announces Transition of Chief Financial Officer - GlobeNewsWire
- 3 months ago - Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire